Andes Biotechnologies

PRESENTATION

Andes Biotechnologies is developing a novel anticancer therapy based on the inactivation of a non-coding RNA target, that selectively eliminates tumor cells of many cancers without harming normal cells. The company is an interesting target for a licensing/trade-sale deal with a larger pharma or biotech player.

PEOPLE

CEO: Cristian Hernandez

Board Members

• Arturo Yudelevich
• Pablo Valenzuela
• Luis Burzio
• Alexander Seelenberger
• Felipe Camposano